Danaher Co. (NYSE:DHR) Holdings Lowered by Flagship Harbor Advisors LLC

Flagship Harbor Advisors LLC lowered its stake in Danaher Co. (NYSE:DHR) by 4.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,928 shares of the conglomerate’s stock after selling 417 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in Danaher were worth $2,049,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Teachers Insurance & Annuity Association of America purchased a new position in Danaher during the 3rd quarter worth approximately $39,000. MidAtlantic Capital Management Inc. acquired a new stake in Danaher during the 3rd quarter valued at $40,000. FSA Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at $50,000. Finally, Darwin Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter worth $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Evercore ISI upped their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Stephens reaffirmed an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. UBS Group cut their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Finally, Robert W. Baird lowered their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $285.55.

Danaher Stock Performance

Shares of DHR opened at $245.95 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a one year low of $225.42 and a one year high of $281.70. The company’s fifty day moving average price is $235.33 and its 200 day moving average price is $253.54. The company has a market capitalization of $177.65 billion, a PE ratio of 46.94, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.